[HTML][HTML] Molecular markers of tubulointerstitial fibrosis and tubular cell damage in patients with chronic kidney disease

S Nakagawa, K Nishihara, H Miyata, H Shinke… - PloS one, 2015 - journals.plos.org
In chronic kidney disease (CKD), progressive nephron loss causes glomerular sclerosis, as
well as tubulointerstitial fibrosis and progressive tubular injury. In this study, we aimed to …

Involvement of autophagy in the pharmacological effects of the mTOR inhibitor everolimus in acute kidney injury

S Nakagawa, K Nishihara, K Inui, S Masuda - European journal of …, 2012 - Elsevier
Inhibitors of mammalian target of rapamycin (mTOR) have immunosuppressive and anti-
cancer effects, but their effects on the progression of kidney disease are not fully understood …

Antibiotic-induced microbiome depletion alters renal glucose metabolism and exacerbates renal injury after ischemia-reperfusion injury in mice

Y Osada, S Nakagawa, K Ishibe… - American Journal …, 2021 - journals.physiology.org
Recent studies have revealed the impact of antibiotic-induced microbiome depletion (AIMD)
on host glucose homeostasis. The kidney has a critical role in systemic glucose …

Urinary chemokine (CC motif) ligand 2 (monocyte chemotactic protein-1) as a tubular injury marker for early detection of cisplatin-induced nephrotoxicity

K Nishihara, S Masuda, H Shinke, A Ozawa… - Biochemical …, 2013 - Elsevier
Because of the difficulty in detecting segment-specific response in the kidney, we
investigated the molecular events underlying acute kidney injury in the proximal tubules of …

Angiotensin II activation of mTOR results in tubulointerstitial fibrosis through loss of N-cadherin

A Whaley-Connell, J Habibi, Z Panfili… - American journal of …, 2011 - karger.com
Background/Aims: Angiotensin (Ang) II contributes to tubulointerstitial fibrosis. Recent data
highlight mammalian target of rapamycin (mTOR)/S6 kinase 1 (S6K1) signaling in …

[HTML][HTML] Identification of key pathways and genes in different types of chronic kidney disease based on WGCNA

Y Guo, J Ma, L Xiao, J Fang, G Li… - Molecular …, 2019 - spandidos-publications.com
Chronic kidney disease (CKD) is a highly heterogeneous nephrosis that occurs when the
structure and function of the kidney is damaged. Gene expression studies have been widely …

Functional involvement of RFVT3/SLC52A3 in intestinal riboflavin absorption

H Yoshimatsu, A Yonezawa, Y Yao… - American Journal …, 2014 - journals.physiology.org
Riboflavin, also known as vitamin B2, is transported across the biological membrane into
various organs by transport systems. Riboflavin transporter RFVT3 is expressed in the small …

Negative feedback loop of autophagy and endoplasmic reticulum stress in rapamycin protection against renal ischemia‐reperfusion injury during initial reperfusion …

X Li, G Zhu, X Gou, W He, H Yin, X Yang… - The FASEB …, 2018 - Wiley Online Library
Rapamycin, an immunosuppressant, is widely used in patients with kidney transplant.
However, the therapeutic effects of rapamycin remain controversial. Additionally, previous …

Effect of simvastatin on expression of transforming growth factor-β and collagen type IV in rat mesangial cells

YB Li, JJ Yin, HJ Wang, J Wang, H Tian, M Yang - Pharmacology, 2011 - karger.com
Objective: Diabetic nephropathy is characterized by the accumulation of extracellular matrix
in the glomerular mesangium as a result of an imbalance between matrix synthesis and …

[PDF][PDF] 富含半胱氨酸蛋白61 对人肾小管上皮细胞增殖与细胞周期的影响

徐岩, 沈学飞, 宋年华, 吴道诩 - 中华肾脏病杂志, 2013 - cjn.org.cn
目的观察富含半胱氨酸蛋白61 (Cyr61) 蛋白对人肾小管上皮细胞(HK⁃ 2)
增殖与细胞周期的影响. 方法细胞被分为空白对照, 阴性对照和Cyr61 转染组. 克隆Cyr61 cDNA …